TCT-292 reduced bleeding complications and increased event-free survival with femoral vascular closure device use and bivalirudin in stemi patients undergoing primary angioplasty in the horizons-ami trial
Timothy A Sanborn,
Roxana Mehran,
Philippe Genereux,
Bernhard Witzenbichler,
Sorin Brener,
Ajay J Kirtane,
Tom McAndrew,
Dominic Francese,
Ran Kornowski,
Dariusz Dudek,
others
January 2013